This heterogeneity presumably reflects genetic, molecular and cellular variables, which may include the presence of neoantigens in only a subset of tumor clones, the expression of PD-L1 in a small proportion of tumor cells, variable expression of PD-1 on immune cells and intra-tumoral differences in T-cell density and clonality58–60. The gene discussed is PDCD1; the disease is neoplasm.